GLP-3 40 mg
This lot was tested by PeptideVerify on 06 Aug 2026. Purity was measured by RP-HPLC, 220 nm. The signed report is reproduced below; the figures on this page are transcribed from it.
- Batch number
- BK-26-0001
- Compound
- GLP-3 40 mg
- Tested
- 06 Aug 2026
- Laboratory
- PeptideVerify
- Purity
- 99.34 % (RP-HPLC, 220 nm)
- Purity, RP-HPLC, 220 nm
- 99.34 %
- Tested
- 06 Aug 2026
- Laboratory
- PeptideVerify
What this certificate shows
Purity 99.34 %. Reversed-phase HPLC separates the contents of the vial by how they interact with the column, and a UV detector measures each peak. 99.34 % of the detected material in lot BK-26-0001 is the target peptide, GLP-3 40 mg; the remaining 0.66 % is made up of closely related sequences and synthesis by-products. Purity describes what the peptide portion is, not how much powder is in the vial.
How each figure is measured, and the limits a lot must meet before release, are set out in our testing methods. For in-vitro laboratory research only.